Back to ACRS
UBS Group AG ACRS Position History
Aclaris Therapeutics, Inc. • Healthcare
Quarters held
14
Latest value
$97K
Q3 2026
Peak value
$2.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3K |
| Q3 2025 | $171K |
| Q3 2025 | $26K |
| Q4 2025 | $5K |
| Q4 2025 | $1.1M |
| Q4 2025 | $334 |
| Q1 2026 | $259 |
| Q1 2026 | $775K |
| Q2 2026 | $4K |
| Q2 2026 | $1.3M |
| Q2 2026 | $104K |
| Q3 2026 | $4K |
| Q3 2026 | $2.4M |
| Q3 2026 | $97K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $97K | 18.5K | — | — |
| Q3 2026 | $2.4M | 465.3K | — | — |
| Q3 2026 | $4K | 702 | — | — |
| Q2 2026 | $104K | 19.6K | — | — |
| Q2 2026 | $1.3M | 236.7K | — | — |
| Q2 2026 | $4K | 702 | — | — |
| Q1 2026 | $775K | 206.7K | — | — |
| Q1 2026 | $259 | 69 | — | — |
| Q4 2025 | $334 | 111 | — | — |
| Q4 2025 | $1.1M | 360.8K | — | — |
| Q4 2025 | $5K | 1.6K | — | — |
| Q3 2025 | $26K | 13.7K | — | — |
| Q3 2025 | $171K | 89.8K | — | — |
| Q3 2025 | $3K | 1.6K | — | — |